SLC3A2

Amino acid transporter heavy chain SLC3A2 · P08195 · SLC3A2 on Sugi Atlas →

0 patent compounds predicted against SLC3A2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC3A2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Kuvan on Melatonin Secretion PHASE4COMPLETED
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies PHASE4COMPLETED
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use PHASE4COMPLETED
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD PHASE3COMPLETED
18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy PHASE3UNKNOWN
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia PHASE1/PHASE2RECRUITING
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® PHASE1/PHASE2COMPLETED
Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure PHASE2UNKNOWN
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
Effect of, OAT3, on the Renal Secretion of Cefotaxime PHASE1COMPLETED
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia PHASE1COMPLETED
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer EARLY_PHASE1UNKNOWN
[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy nanUNKNOWN
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs nanCOMPLETED
CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberrant Nerve Sprouting nanUNKNOWN
Characterization of Breg Cells nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
SLC13A5 Deficiency Natural History Study - Remote Only nanENROLLING_BY_INVITATION
A Study of Cases with Abnormal Serum Ammonia in Neonate and Children Attending Assiut University Children Hospital nanNOT_YET_RECRUITING
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia nanCOMPLETED
Choroid Plexus Dysfunction in Neurological Diseases nanRECRUITING
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management nanUNKNOWN
Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle nanCOMPLETED
Fluorescence and Glioma Heterogeneity nanCOMPLETED
Protein Digestion and Amino Acid Absorption in the Aging Gastrointestinal Tract nanCOMPLETED
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers nanCOMPLETED
Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC3A2 binder may also engage these)

ProteinNameSimilarity
Q794F9 0.992 Q794F9 →
P10852 0.991 P10852 →
Q7YQK3 0.988 Q7YQK3 →
Q4R4I0 0.964 Q4R4I0 →
NECTIN4 Nectin-4 0.963 landscape →
TERF2IP Telomeric repeat-binding factor 2-interacting protein 1 0.962 landscape →
Q8R007 0.962 Q8R007 →
Q3B7U9 0.962 Q3B7U9 →
O35465 0.961 O35465 →
Q91ZT7 0.960 Q91ZT7 →
Q6MZW2 0.960 Q6MZW2 →
Q0VCT3 0.960 Q0VCT3 →
Q5STE3 0.959 Q5STE3 →
Q5E9Z9 0.959 Q5E9Z9 →
Q3TAA7 0.958 Q3TAA7 →
G5E872 0.957 G5E872 →
Q6AYG3 0.957 Q6AYG3 →
Q8C190 0.957 Q8C190 →
A4D0V7 0.957 A4D0V7 →
P50555 0.957 P50555 →
Q496Y0 0.956 Q496Y0 →
HLCS Biotin--protein ligase 0.956 landscape →
Q6YGZ1 0.956 Q6YGZ1 →
Q920N2 0.956 Q920N2 →
O19131 0.956 O19131 →
O75129 0.956 O75129 →
P54831 0.956 P54831 →
P97492 0.956 P97492 →
Q6ZT62 0.956 Q6ZT62 →
Q91WA6 0.956 Q91WA6 →